Northern Trust
BCAB icon

Northern Trust’s BioAtla BCAB Stock Holding History

Northern Trust’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Hold
2,070
– – ﹤0.01% 4348
2025
Q4 		$58.8K Buy
2,070
+53
+3% +$2.08K ﹤0.01% 4250
2025
Q3 		$69.4K Hold
2,017
– – ﹤0.01% 4217
2025
Q2 		$39.9K Hold
2,017
– – ﹤0.01% 4268
2025
Q1 		$35K Buy
2,017
+1
+0% +$21 ﹤0.01% 4283
2024
Q4 		$59.6K Buy
2,016
+240
+14% +$20.1K ﹤0.01% 4242
2024
Q3 		$156K Sell
1,776
-4,775
-73% -$400K ﹤0.01% 3952
2024
Q2 		$449K Sell
6,551
-528
-7% -$62.8K ﹤0.01% 3546
2024
Q1 		$1.22M Sell
7,079
-39
-0.5% -$4.85K ﹤0.01% 3227
2023
Q4 		$875K Sell
7,118
-29
-0.4% -$2.51K ﹤0.01% 3357
2023
Q3 		$608K Sell
7,147
-149
-2% -$19K ﹤0.01% 3462
2023
Q2 		$1.09M Buy
7,296
+5,488
+304% +$944K ﹤0.01% 3324
2023
Q1 		$242K Buy
1,808
+100
+6% +$18K ﹤0.01% 3771
2022
Q4 		$704K Buy
1,708
+271
+19% +$112K ﹤0.01% 3384
2022
Q3 		$553K Buy
1,437
+361
+34% +$118K ﹤0.01% 3475
2022
Q2 		$153K Sell
1,076
-2,405
-69% -$383K ﹤0.01% 4018
2022
Q1 		$871K Sell
3,481
-120
-3% -$50.2K ﹤0.01% 3489
2021
Q4 		$3.54M Buy
3,601
+77
+2% +$98.5K ﹤0.01% 2911
2021
Q3 		$5.19M Buy
3,524
+581
+20% +$1.13M ﹤0.01% 2707
2021
Q2 		$6.24M Buy
2,943
+488
+20% +$1.1M ﹤0.01% 2715
2021
Q1 		$6.24M Buy
+2,455
New +$6.29M ﹤0.01% 2611

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust's BCAB Position: Q1 2026 in Review

Northern Trust held its BioAtla (BCAB) position steady in Q1 2026 at 2,070 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4348.

Northern Trust first reported a position in BCAB in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.24M in Q1 2021. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Northern Trust held 2,070 shares of BioAtla worth $16.7K as of Q1 2026.
  • Northern Trust left its BioAtla share count unchanged in Q1 2026.
  • BioAtla made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4348 holding.
  • Northern Trust first reported a position in BioAtla in Q1 2021 and has held it in 21 quarters since.
  • Northern Trust's BioAtla position peaked at $6.24M in Q1 2021.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.